Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
NCT ID: NCT04662918
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2022-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Methods to Predict PHG in Cirrhosis
NCT03513900
Position Changes in Cirrhosis Hemorrhagic Spot Detection
NCT05165043
Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography
NCT04640350
ASSESSMENT OF SURGICAL RISK IN PATIENTS WITH CHRONIC LIVER DISEASE USING VOCAL PENN SCORE
NCT06227988
Clinical Characteristics Analysis and Prediction Model Establishment of Fatal Esophageal and Gastric Variceal Bleeding
NCT05613309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with acute gastrointestinal bleeding presenting with hematemesis, melena, and/or hematochezia;
3. Adults (age≥18 years old).
Exclusion Criteria
2. In-hospital outcomes are not evaluable.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xingshun Qi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xingshun Qi
Dr., Associate Professor, Vice-Chief Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Wright Center for Graduate Medical Education, 501 S. Washington Avenue
Scranton, Pennsylvania, United States
São Paulo State University (UNESP), Botucatu Medical School
São Paulo, São Paulo, Brazil
Beijing Youan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
The Seventh Medical Center of Chinese PLA General Hospital
Beijing, Beijing Municipality, China
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The Six People's Hospital of Dalian
Dalian, Liaoning, China
Air Force Hospital of Northern Theater Command
Shenyang, Liaoning, China
General Hospital of Northern Theater Command
Shenyang, Liaoning, China
The First Hospital of China Medical University
Shenyang, Liaoning, China
The Six People's Hospital of Shenyang
Shenyang, Liaoning, China
Tangdu Hospital, Fourth Military Medical University,
Xi'an, Shaanxi, China
The First Affiliated Hospital of Xi'an Jiao Tong University
Xi'an, Shaanxi, China
The Second Affiliated Hospital of Xi'an Jiao Tong University
Xi'an, Shaanxi, China
Xi'an Central Hospital
Xi'an, Shaanxi, China
Shandong Provincial Hospital
Jinan, Shandong, China
Cathay General Hospital, Fu-Jen Catholic University School of Medicine
Taibei, Taiwan, China
Charité University Medical Center
Berlin, State of Berlin, Germany
Ernakulam Medical Center
Kochi, Kochi, India
Azienda di Rilievo Nazionale ad Alta Specializzazione Civico-Di Cristina-Benfratelli
Palermo, Palermo, Italy
National Autonomous University of Mexico
Mexico City, Mexico City, Mexico
Bezmialem Vakif University
Istanbul, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Bai Z, Li B, Lin S, Liu B, Li Y, Zhu Q, Wu Y, Yang Y, Tang S, Meng F, Chen Y, Yuan S, Shao L, Qi X. Development and Validation of CAGIB Score for Evaluating the Prognosis of Cirrhosis with Acute Gastrointestinal Bleeding: A Retrospective Multicenter Study. Adv Ther. 2019 Nov;36(11):3211-3220. doi: 10.1007/s12325-019-01083-5. Epub 2019 Sep 11.
Bai Z, Lin S, Sun M, Yuan S, Marcondes MB, Ma D, Zhu Q, Li Y, He Y, Philips CA, Liu X, Pinyopornpanish K, Shao L, Mendez-Sanchez N, Basaranoglu M, Wu Y, Chen Y, Yang L, Mancuso A, Tacke F, Li B, Liu L, Ji F, Qi X. Machine learning based CAGIB score predicts in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding. NPJ Digit Med. 2025 Jul 31;8(1):489. doi: 10.1038/s41746-025-01883-w.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V-CAGIB 1.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.